APAC's employer medical benefit costs may rise 8.7% in 2020 | Healthcare Asia Magazine
, Singapore

APAC's employer medical benefit costs may rise 8.7% in 2020

This growth will be led by Malaysia and Thailand.

Employer-provided medical benefit costs in the Asia Pacific are poised to grow to 8.7% in 2020 from 8.6% in 2019, according to a report from Aon.

Employers in Malaysia and Thailand will need to shell out more as costs are tipped to increase the largest by 14% and 13.9% respectively by 2020.

China and Hong Kong are projected to see an average medical trend rate increase of 7.5% and 8.1% respectively. In China, the adoption of advanced technology has pushed up the prices of medical goods and services at a level two to three times the general inflation whilst increasing levels of stress and respiratory infections is driving the medical trend rate in Hong Kong.

Indonesia and Taiwan will see their respective 2020 medical trend rates hold steady at 13% and 8% respectively.

Meanwhile, employer-provided medical benefit costs in Singapore are tipped to rise by 10% in 2020 which will outpace the average general inflation rate of 1.4%. Its higher costs are attributed to an ageing population and a rise in chronic diseases like diabetes and high blood pressure.

Also read: Singapore needs to control inpatient costs amidst high medical inflation

On the other hand, India, Japan, Malaysia, the Philippines, South Korea, Thailand and Vietnam will witness declining medical trend rates on a YoY basis to 2020.

The global average medical trend rate for 2020 is tipped to hit 8% in 2020 from 7.8% in 2019. On a per region basis, North America will see medical trend rate hit 6.4%, Europe at 5.7%, Latin America and Caribbean at 13.1% and Middle East & Africa at 12.2%.

The survey was conducted amongst the 105 Aon Offices that broker, administer or advise on employer-sponsored medical plans in each of the countries under the report’s coverage.

Pemindaian AI terkini meningkatkan diagnosa di Shin Kong Wu Ho-Su Memorial Hospital

Rumah sakit di Taiwan ini menggunakan teknologi endoskop yang dibantu AI untuk mendeteksi polip dan kamera resolusi tinggi untuk telemedis.

Kejeniusan dalam ‘SuperApps’ untuk perawatan kesehatan adalah akses dan jangkauan

Rumah sakit yang merangkul digitalisasi tetap unggul dalam layanan kesehatan.

Rumah Sakit Kanker Dharmais memimpin inovasi pelayanan kanker di Indonesia

Direktur Utama RS Kanker Dharmais Soeko Werdi Nindito Daroekoesoemo mengungkapkan teknologi canggih dan tujuh program unggulan untuk perawatan kanker.

Healthway Cancer Care Hospital memajukan perawatan holistik dengan harga yang wajar

Rumah sakit mengharapkan program kualitas dan kelangsungan hidup yang melayani keseluruhan perjalanan pasien.

MakatiMed menuju perawatan bedah presisi dengan sistem robotik Da Vinci Xi

Teknologi ini memungkinkan teknik invasif minimal dalam bidang urologi, hepatobilier, kardiovaskular, toraks, kebidanan dan ginekologi, serta bedah umum.

Indonesia memperluas dukungan solusi kesehatan menggunakan AI

Kolaborasi dengan Google Cloud sejalan dengan cetak biru pemerintah untuk transformasi kesehatan digital.

Indonesia merancang rencana induk untuk pengembangan kesehatan terpadu

Rencana induk sektor kesehatan negara (RIBK) selaras dengan mandat Undang-Undang Kesehatan Nomor 17 Tahun 2023.

The Medical City membuka jalan bagi integrasi AI dalam layanan kesehatan lokal dan penelitian dengan Lunit

AI telah diintegrasikan ke dalam layanan mamografi dan rontgen dada di jaringan rumah sakit ini.

Mayapada Healthcare Group meraih prestasi besar di Healthcare Asia Awards 2024

Pendekatan holistik yang dilakukan oleh rumah sakit tersebut mendorongnya maju dan menjadi standar industri.

Rumah Sakit Kanker Dharmais meraih dua kemenangan di Healthcare Asia Awards 2024

Sumber daya manusia yang kompeten, layanan, fasilitas, dan infrastruktur unggul membantu rumah sakit memberikan perawatan pasien yang sangat baik.